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Abstract: Central Serous Chorioretinopathy (CSC) is a condition where there is an 
accumulation of serous fluid in the retinal pigment epithelium layer. The 
abnormality in the retinal pigment layer of the eye causes vision loss and serous 
detachment. CSC has a variety of causes, one of which is corticosteroid therapy. 
This article aims to report a case of a 27-year-old male patient who was diagnosed 
with CSC. The risk factor indicating CSC, in this case, was long-term oral and the 
use of a nasal spray to treat patient’s allergic rhinitis. Patients have allergic rhinitis 
and sneezing. Thus, they are administered to consume tablets of 16 mg 
methylprednisolone three times a day. The patient has a history of using a nasal 
spray containing 0.05% mometasone furoate monohydrate for ten years in a row. 
The patient’s visual acuity is 6/6 on his right eye and 6/15 on his left eye. Posterior 
segment examination and optical coherence tomography (OCT) were considered 
effective in identifying the features of patients with CSC, and thus both were 
administered. It was further found that steroid therapy replacement and healthier 
lifestyle adjustments could sustain the symptoms and improve the patient’s well-
being. 
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Abstrak: Central Serous Chorioretinopathy (CSC) adalah suatu kondisi di mana terdapat 
akumulasi cairan serosa dalam lapisan epitel pigmen retina yang dapat menyebabkan  
terlepasnya lapisan neurosensori retina. CSC memiliki berbagai penyebab termasuk terapi 
kortikosteroid. Artikel ini ditulis untuk melaporkan seorang pria dengan diagnosis CSC. 
Faktor risiko untuk CSC dalam kasus ini adalah penggunaan steroid oral dan semprotan 
nasal jangka panjang karena rinitis alergi. Pasien memiliki rinitis alergi dan bersin dan 
terbiasa menggunakan tablet metilprednisolon 16 mg tiga kali sehari ketika ia merasa alergi. 
Pasien memiliki riwayat menggunakan semprotan hidung yang mengandung 0,05% 
mometasone furoate monohydrate selama 10 tahun berturut-turut. Ketajaman visual pasien 
masing-masing adalah 6/6 dan 6/15 untuk mata kanan dan kiri dengan beberapa fitur 
CSC dalam pemeriksaan segmen posterior dan Optical Coherence Tomography (OCT). 
Penggantian terapi steroid dan modifikasi gaya hidup menurunkan gejala dan kualitas hidup 
pasien. 
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Central Serous Chorioretinopathy (CSC) is the 
fourth most non-surgical retinopathy after age-
related macular degeneration (AMD), diabetic 
retinopathy (DR), and Branch Retinal Vein Occlusion 
(BRVO).1  Males have a higher prevalence of CSC 
than female according to some literature reports.2-4  
Central Serous Chorioretinopathy (CSC) is a 
condition where there is an accumulation of serous 
fluid in the r etinal pigment epithelium layer, which 
causes detachment of the retinal neurosensory. CSC 
has a variety of causes and is usually related to 
several conditions. Middle age, type A personality, 
narcissistic personality, corticosteroid therapy, post 
vitrectomy surgery, heart, spinal cord and kidney 
transplant, conditions involving cortisol such as 
Cushing’s disease and pregnancy, hypertension, 
sleep apnea, smoking, alcohol consumption, 
antihistamines, asthma to gastroesophageal reflux 
(GERD) are known to be a risk factor for CSC.5  This 
article aims to report a man with a CSC diagnosed 
with risk factors for long-term oral steroid use. from 
non-communicable diseases such as cancer, heart 




A 27-year-old man came with a complaint of 
left eye blurred in the last one week. The patient 
experienced an indistinct vision for two days 
straight. The decrease in visual acuity in the 
mentioned patient was accompanied by dizziness 
when seeing with both eyes. Patients had allergic 
rhinitis and sneezing and were accustomed to using 
tablets of methylprednisolone 16 mg three times a 
day when he felt the allergic reactions. This habit 
has been carried out by patients for about ten 
years. The patient also had a history of using a nasal 
spray containing 0.05% mometasone furoate 
monohydrate, which was used when the patient's 
nose felt congested. The patient did not have a 
history of high blood pressure, diabetes, or 
cholesterol. 
Ophthalmology examination results showed 
visual acuity of the right eye was 6/6, and the left 
eye was 6/15. The results of a field examination with 
confrontation showed no peripheral visual field 
disturbances in both eyes. The results of the 
examination with Goldman perimetry showed a 
normal vision in the right eye and a central scotoma 
in the left eye. Intraocular pressure for both eyes 
was 15. Examination using the Amsler grid showed 
metamorphopsia in the left eye vision. The 
posterior segment examined by using indirect 
ophthalmoscopy with a 20 D lens in both eyes 
revealed different images. The posterior segment 
of the patient's right eye showed within normal 
limits with a uniform fundus reflex, a clear border of 
the optic nerve, and vital color with 0.3 cup disc 
ratio (CDR). The patient's left eye retina showed a 
picture of minimal edema with a yellowish circle 
with unclear boundaries with a normal disc 
appearance (Figure 1). The patient was consulted 
for an examination of Optical Coherence 
Tomography (OCT). OCT examination showed 
subretinal fluid with the 285-micrometer central 
retinal thickness (Figure 2). 
The patient was diagnosed with right eye 
emmetropia and central serous left eye 
chorioretinopathy with allergic rhinitis. The 
management of this patient was vitamin B6 three 
times daily and is administered to the Ear Nose 
Throat and neck (ENT) department for further 
treatment of allergic rhinitis. The patient was also 
given information regarding the patient's eye 
disease and steroid use as a risk factor and was 
advised not to use methylprednisolone tablets 
without a doctor's prescription. 
 
 
Figure 1. Fundus Photo of the left eye. 
 
 





Upon the two-month therapy, the patient 
came back with the left eye’s vision condition to be 
improved. Mometasone furoate monohydrate of 
0.05% nasal spray was changed to 0.1% of 
Xylometazoline HCL. On the ophthalmology 
examination, the patient's right and left eye visual 
acuity were 6/6. The examination with the Amsler 
grid did not show any metamorphopsia in both 
eyes. The results of the cross-section with Goldman 
perimetry showed a normal visual condition in both 
eyes. The posterior segment of both eyes showed a 
uniform fundus reflex, a clear border of the optic 
nerve, vital color with cup disc ratio 0.3, as well as -
retina and macula within normal limits. The results 
of the left eye OCT examination showed normal 
OCT with a macular thickness of 227 micrometers 
for the left eye. The patient was subsequently 
diagnosed with right eye emmetropia and the left 





CSC is a retinal disease characterized by an 
accumulation of subretinal fluid. This buildup of 
fluid can cause retinal detachment, which ultimately 
disrupts vision that leads to blindness.   
Choriocapillaris malfunction, choroidal 
hyperpermeability, and abnormal choroidal 
thickness are believed to be the main pathologies of 
CSC.6 This patient, a respondent in this study, used 
Mometasone Furoate as a nasal spray. It has been a 
habit for the past 10 years. Methylprednisolone and 
Mometasone Furoate are derivatives of 
Glucocorticoid hormone, which acts like a hormone 
produced by the adrenal cortex.7 Inhaled 
glucocorticoids can be absorbed into the body and 
have a systemic effect. This absorption is influenced 
by various factors, including corticosteroid particle 
size, absorption, and metabolism of the drugs 
consumed.8   Inhaled corticosteroids have the 
potential to be absorbed into the systemic 
circulation as much as 13 - 39%.9 
Corticosteroids are one of the most frequent 
therapeutic choices in handling allergic cases. On 
the other hand, the use of corticosteroids results in 
inhibition of neutrophil attachment to the 
endothelium, a decrease in chemotaxis from 
neutrophils and monocytes, and inhibition of 
phagocytosis and intercellular resistance to 
microorganisms. Other side effects of 
corticosteroid use include Cushing's syndrome, 
peptic ulcer disease, benign intracranial 
hypertension, psychosis, glaucoma, posterior 
subcapsular cataracts, paraplegia, hypertension, 
diabetic ketoacidosis, hyperglycemia, myopathy, 
osteoporosis, and also as included in this case 
report, central serous chorioretinopathy.10-27 
Although the pathophysiology of CSC is still 
unclear, it is identified that glucocorticoid 
hormones work by binding to glucocorticoid 
receptors. This hormone is produced in the adrenal 
cortex and retinal pigment epithelium. It results in 
high concentrations of glucocorticoid hormones in 
the eyeball compared to blood plasma.28 
Glucocorticoid derivatives in the eye are such as 
cortisol. A function of the hormone cortisol is such 
as maintaining homeostasis.29 Excessive hormone 
cortisol results in hyperpermeability of the choroid 
blood vessels, eventually increasing hydrostatic 
tissue pressure and ultimately damaging the barrier 
function of the retinal pigment epithelium. This 
increase can result in damage to the retinal 
fragment epithelium, which leads to an 
accumulation of subretinal fluid.2 This finding is in 
line with the findings on the examination of the 
posterior segment of the patient where it revealed 
an appearance of minimal edema with a yellowish 
circle with unclear boundaries. 
Further examination performed on this patient 
was an Optical Coherence Tomography (OCT) 
examination. OCT is the latest modality in 
ophthalmology to examine a retina. This OCT shows 
a cross-section of the retina and is non-invasive, and 
thus it is safe to use in diagnostic enforcement.30,31 
The OCT findings in this patient were in the form of 
subretinal fluid which was a marker of diagnosis of 
CSC.5 
The treatment given to these patients was 
10mg pyridoxine (vitamin B6) tablet three times a 
day. This dose is below the daily recommended 
dose of 1-25 mg. In addition, to function as a nerve 
protector, pyridoxine is also useful as a placebo 
effect in patients while waiting for an increase in 
disease.32 Long-term administration of pyridoxine 
can lead to toxicity of pyridoxine in the skin, 
digestive tract, and nervous system. Thus, vitamin 
B6 is needed in amino acid metabolism, 
carbohydrates and lipids. The side effects of 
pyridoxine can also be neuropathy including, 
hypoesthesia, paraesthesia, peripheral neuropathy, 
muscle weakness, disturbances in walking and 
balance, and other complaints.33-35 CSC can lead to 
blindness, but it can also heal on its own within 3-4 
months in some cases.5 Therefore, other therapies 
other than Piridoxin are not given to these 
patients.36  The condition of stress and depression 
in patients contributes to increased cortisol levels.23 
Stress that induced CSC can occur in any profession, 
including medical workers. Stress management was 
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Posterior segment examination and optical 
coherence tomography were considered effective 
in identifying the features of patients with CSC, and 
thus, both were administered. It was further 
revealed that steroid therapy replacement and 
healthier lifestyle adjustments could sustain the 
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